603858.SS
603858.SS
CNE100002FV6
SHANDONG BUCHANG PHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 (Est.) Change %
Total Revenue 11.875.013.010 0
--
Cost of Revenue 4.399.990.372 --
--
Gross Profit 7.475.022.638 --
--
5.999.510.705 --
--
Operating Income 1.475.511.933 --
--
Pretax Income 533.955.472 --
--
Net Income Common Stockholders 360.784.856 --
--
-- --
--
-- --
--
ende